These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9190895)

  • 1. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis.
    Cheng JQ; Altomare DA; Klein MA; Lee WC; Kruh GD; Lissy NA; Testa JR
    Oncogene; 1997 Jun; 14(23):2793-801. PubMed ID: 9190895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
    Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
    Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin.
    Altomare DA; Lyons GE; Mitsuuchi Y; Cheng JQ; Testa JR
    Oncogene; 1998 May; 16(18):2407-11. PubMed ID: 9620559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
    Altomare DA; Guo K; Cheng JQ; Sonoda G; Walsh K; Testa JR
    Oncogene; 1995 Sep; 11(6):1055-60. PubMed ID: 7566964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2.
    Mitsuuchi Y; Johnson SW; Sonoda G; Tanno S; Golemis EA; Testa JR
    Oncogene; 1999 Sep; 18(35):4891-8. PubMed ID: 10490823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3.
    Mende I; Malstrom S; Tsichlis PN; Vogt PK; Aoki M
    Oncogene; 2001 Jul; 20(32):4419-23. PubMed ID: 11466625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
    Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
    Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
    Liu AX; Testa JR; Hamilton TC; Jove R; Nicosia SV; Cheng JQ
    Cancer Res; 1998 Jul; 58(14):2973-7. PubMed ID: 9679957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
    Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products.
    Toksoz D; Williams DA
    Oncogene; 1994 Feb; 9(2):621-8. PubMed ID: 8290273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
    Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
    Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
    Cheng JQ; Godwin AK; Bellacosa A; Taguchi T; Franke TF; Hamilton TC; Tsichlis PN; Testa JR
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9267-71. PubMed ID: 1409633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
    Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
    Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.
    Bischoff JR; Anderson L; Zhu Y; Mossie K; Ng L; Souza B; Schryver B; Flanagan P; Clairvoyant F; Ginther C; Chan CS; Novotny M; Slamon DJ; Plowman GD
    EMBO J; 1998 Jun; 17(11):3052-65. PubMed ID: 9606188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
    Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
    Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
    Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.
    Arboleda MJ; Lyons JF; Kabbinavar FF; Bray MR; Snow BE; Ayala R; Danino M; Karlan BY; Slamon DJ
    Cancer Res; 2003 Jan; 63(1):196-206. PubMed ID: 12517798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.